Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-23T13:11:58.505Z Has data issue: false hasContentIssue false
  • English
  • Français

Drug-induced aseptic meningitis secondary to trimethoprim/sulfamethoxazole: a headache to be aware of

Published online by Cambridge University Press:  04 March 2015

Joel R. Lockwood  and
David Carr
Joel R. Lockwood*
Affiliation:
Division of Emergency Medicine, Department of Medicine, University of Toronto, Toronto, ON
David Carr
Affiliation:
Division of Emergency Medicine, Department of Medicine, University of Toronto, Toronto, ON
*
2075 Bayview Avenue, C753, Toronto, ON M4N 3N5; [email protected]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Trimethoprim/sulfamethoxazole (TMP/SMX), also known as Septra, is a commonly encountered and prescribed antibiotic in emergency department patients. The side effects associated with TMP/SMX are generally mild and self-limited, but serious side effects, including Stevens-Johnson syndrome and drug-induced aseptic meningitis, have been reported. We discuss the case of a 33-year-old woman who presented to our emergency department with the signs and symptoms of meningeal inflammation after being prescribed TMP/SMX 3 days earlier for an abscess with cellulitis.

Keywords

aseptic meningitisdrug toxicityemergency medicinetrimethoprim/sulfamethoxazole
Type
Case Report • Rapport de cas
Information
Canadian Journal of Emergency Medicine , Volume 16 , Issue 5 , September 2014 , pp. 421 - 424
Copyright
Copyright © Canadian Association of Emergency Physicians 2014

References

REFERENCES

1. van de Beek, D, de Gans, J, Spanjaard, L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;352:1849–59, doi:10.1056/NEJMoa040845.Google Scholar
2. Thigpen, MC, Whitney, CG, Messonnier, NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011;364:2016–25, doi:10.1056/NEJMoa1005384.Google Scholar
3. Shears, P. Emerging and reemerging infections in Africa: the need for improved laboratory services and disease surveillance. Microbes Infect 2000;2:489–95, doi:10.1016/S1286-4579(00)00309-9.CrossRefGoogle ScholarPubMed
4. Scheld, WM, Koedel, U, Nathan, B, et al. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis 2002;186 Suppl 2:S225-33, doi:10.1086/344939.Google Scholar
5. Aronin, SI, Peduzzi, P, Quagliarello, VJ. Communityacquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998;129:862–9, doi:10.7326/0003-4819-129-11_Part_1-199812010-00004.CrossRefGoogle ScholarPubMed
6. Irani, DN. Aseptic meningitis and viral myelitis. Neurol Clin 2008;26:635–55, vii-viii, doi:10.1016/j.ncl.2008.03.003.Google Scholar
7. Moris, G, Garcia-Monco, JC. The challenge of drug-induced asepticmeningitis. Arch Intern Med 1999;159:1185–94, doi:10.1001/archinte.159.11.1185.Google Scholar
8. Mifsud, AJ. Drug-related recurrent meningitis. J Infect 1988;17:151–3, doi:10.1016/S0163-4453(88)91739-2.Google Scholar
9. Capra, C, Monza, GM, Meazza, G, et al. Trimethoprimsulfamethoxazole-induced aseptic meningitis: case report and literature review. Intensive Care Med 2000;26:212–4, doi:10.1007/s001340050048.Google Scholar
10. Harrison, MS, Simonte, SJ, Kauffman, CA. Trimethopriminduced aseptic meningitis in a patient with AIDS: case report and review. Clin Infect Dis 1994;19:431–4, doi:10.1093/clinids/19.3.431.Google Scholar
11. Gordon, MF, Allon, M, Coyle, PK. Drug-induced meningitis. Neurology 1990;40:163–4, doi:10.1212/WNL.40.1.163.Google Scholar
12. Joffe, AM, Farley, JD, Linden, D, et al. Trimethoprimsulfamethoxazole-associated aseptic meningitis: case reports and review of the literature. Am J Med 1989;87:332–8, doi:10.1016/S0002-9343(89)80160-3.Google Scholar